Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients

Mycobacterium abscessus is difficult to eradicate. At the Montpellier CF Center, we prescribed liposomal amikacin for inhalation to 5 patients with M abscessus infection. The 3 patients who completed the treatment did not have any respiratory exacerbation, showed negative cultures for M abscessus in...

Descripción completa

Detalles Bibliográficos
Autores principales: Caimmi, Davide, Martocq, Nicolas, Trioleyre, Delphine, Guinet, Catherine, Godreuil, Sylvain, Daniel, Thomas, Chiron, Raphael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846290/
https://www.ncbi.nlm.nih.gov/pubmed/29564361
http://dx.doi.org/10.1093/ofid/ofy034
_version_ 1783305561288212480
author Caimmi, Davide
Martocq, Nicolas
Trioleyre, Delphine
Guinet, Catherine
Godreuil, Sylvain
Daniel, Thomas
Chiron, Raphael
author_facet Caimmi, Davide
Martocq, Nicolas
Trioleyre, Delphine
Guinet, Catherine
Godreuil, Sylvain
Daniel, Thomas
Chiron, Raphael
author_sort Caimmi, Davide
collection PubMed
description Mycobacterium abscessus is difficult to eradicate. At the Montpellier CF Center, we prescribed liposomal amikacin for inhalation to 5 patients with M abscessus infection. The 3 patients who completed the treatment did not have any respiratory exacerbation, showed negative cultures for M abscessus in their sputum, and stabilized their spirometric functions.
format Online
Article
Text
id pubmed-5846290
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58462902018-03-21 Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients Caimmi, Davide Martocq, Nicolas Trioleyre, Delphine Guinet, Catherine Godreuil, Sylvain Daniel, Thomas Chiron, Raphael Open Forum Infect Dis Brief Report Mycobacterium abscessus is difficult to eradicate. At the Montpellier CF Center, we prescribed liposomal amikacin for inhalation to 5 patients with M abscessus infection. The 3 patients who completed the treatment did not have any respiratory exacerbation, showed negative cultures for M abscessus in their sputum, and stabilized their spirometric functions. Oxford University Press 2018-02-17 /pmc/articles/PMC5846290/ /pubmed/29564361 http://dx.doi.org/10.1093/ofid/ofy034 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Caimmi, Davide
Martocq, Nicolas
Trioleyre, Delphine
Guinet, Catherine
Godreuil, Sylvain
Daniel, Thomas
Chiron, Raphael
Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title_full Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title_fullStr Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title_full_unstemmed Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title_short Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
title_sort positive effect of liposomal amikacin for inhalation on mycobacterium abcessus in cystic fibrosis patients
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846290/
https://www.ncbi.nlm.nih.gov/pubmed/29564361
http://dx.doi.org/10.1093/ofid/ofy034
work_keys_str_mv AT caimmidavide positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT martocqnicolas positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT trioleyredelphine positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT guinetcatherine positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT godreuilsylvain positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT danielthomas positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients
AT chironraphael positiveeffectofliposomalamikacinforinhalationonmycobacteriumabcessusincysticfibrosispatients

Ejemplares similares